China Biologic Products (CBPO) Tops Q1 EPS by 11c

China Biologic Products (NASDAQ: CBPO) reported Q1 EPS of $1.11, $0.11 better than the analyst estimate of $1.00. Revenue for the quarter came in at $129.8 million versus the consensus estimate of $122 million.

For earnings history and earnings-related data on China Biologic Products (CBPO) click here.

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Marpai, Inc. (MRAI) Misses Q2 EPS by 18c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c